Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Change in Inventory (2022 - 2025)

Historic Change in Inventory for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to -$27735.0.

  • 60 Degrees Pharmaceuticals' Change in Inventory fell 20660.75% to -$27735.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $319650.0, marking a year-over-year increase of 29178.04%. This contributed to the annual value of -$23405.0 for FY2024, which is 8899.87% up from last year.
  • 60 Degrees Pharmaceuticals' Change in Inventory amounted to -$27735.0 in Q3 2025, which was down 20660.75% from $26183.0 recorded in Q2 2025.
  • 60 Degrees Pharmaceuticals' 5-year Change in Inventory high stood at $330474.0 for Q1 2025, and its period low was -$152542.0 during Q4 2023.
  • Its 4-year average for Change in Inventory is $1973.7, with a median of -$20571.0 in 2022.
  • As far as peak fluctuations go, 60 Degrees Pharmaceuticals' Change in Inventory plummeted by 22775.83% in 2023, and later surged by 117324.63% in 2025.
  • 60 Degrees Pharmaceuticals' Change in Inventory (Quarter) stood at -$46541.0 in 2022, then tumbled by 227.76% to -$152542.0 in 2023, then surged by 93.92% to -$9272.0 in 2024, then plummeted by 199.13% to -$27735.0 in 2025.
  • Its Change in Inventory was -$27735.0 in Q3 2025, compared to $26183.0 in Q2 2025 and $330474.0 in Q1 2025.